Far from easy and accurate - Detection of metabolic syndrome by general practitioners

BMC Family Practice

Volumn 10, Issue , 2009, Pages

  Helminen, Eeva Eerika ^a,b   Mäntyselkä, Pekka ^b,c   Nykänen, Irma ^c   Kumpusalo, Esko ^b,c  

^a Kuopio Health Centre   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; DIAGNOSTIC ACCURACY; FEMALE; FINLAND; GENERAL PRACTITIONER; HEALTH SURVEY; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIMARY MEDICAL CARE; QUESTIONNAIRE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; ATTITUDE TO HEALTH; CLINICAL COMPETENCE; COMORBIDITY; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; DOCTOR PATIENT RELATION; HEALTH PERSONNEL ATTITUDE; HEALTH STATUS; MIDDLE AGED; PSYCHOLOGICAL ASPECT; STANDARD; STATISTICS;

AGED; ATTITUDE OF HEALTH PERSONNEL; ATTITUDE TO HEALTH; CLINICAL COMPETENCE; COMORBIDITY; CORONARY DISEASE; FEMALE; FINLAND; HEALTH STATUS; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PHYSICIAN-PATIENT RELATIONS; PHYSICIANS, FAMILY; QUESTIONNAIRES; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 72849126814     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/1471-2296-10-76     Document Type: Article

References (22)

1. Report of a WHO consultation, Obesity: preventing and managing the global epidemic. World Health Organization, Geneva: World Health Organization 2000
2. Global and societal implications of the diabetes epidemic. P Zimmet KG Alberti J Shaw, Nature 2001 414 782 787
3. The use of a diagnostic code for the metabolic syndrome in the US. EF Ford Rarer than a blue moon, Diabetes Care 2005 28 1808 1809
4. Prevalence of undiagnosed metabolic syndrome in a population of adult asymptomatic subjects. S Bo G Ciccone N Pearce F Merletti L Gentile M Cassader G Pagano, Diabetes Res Clin Pract 2007 75 362 365
5. Metabolic syndrome: To be or not to be? M Laakso PT Kovanen, Ann Intern Med 2006 38 32 33
6. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Executive summary of the third report of The National Cholesterol Education Program (NCEP), JAMA 2001 285 2486 2497
7. The metabolic syndrome: a new world-wide definition. KG Alberti P Zimmet J Shaw, Lancet 2005 366 1059 1062 (Pubitemid 41338752)
8. Prevalence of the metabolic syndrome and its components: findings from a Finnish general population sample and the Diabetes Prevention Study Cohort. P Ilanne-Parikka JG Eriksson J Linström H Hämäläinen S Keinänen-Kiukaanniemi M Laakso A Louheranta M Mannelin M Rastas V Salminen S Aunola J Sundvall T Valle J Lahtela M Uusitupa J Tuomilehto Finnish Diabetes Prevention Study Group, Diabetes Care 2004 27 2135 2140
9. [Hypertension and insulin resistance]. J Kuusisto M Laakso, Suomen Lääkärilehti 1992 33 3114 (in Finnish)
10. [Classification of hyperlipidemias]. M Vanhala, [Physician's Handbook] Helsinki, Duodecim Medical Publications Ltd, Edited by: Kunnamo I, 1996 676 677 (in Finnish)
11. [Metabolic syndrome]. M Vanhala, [Physician's Handbook] Helsinki, Duodecim Medical Publication Ltd, Edited by: Kunnamo I, 2004 786 787 (in Finnish)
12. Should we dump the metabolic syndrome? No. KG Alberti PZ Zimmet, BMJ 2008 336 641
13. The metabolic syndrome: requiescat in pace. GM Reaven, Clin Chem 2005 51 931 940
14. Should we dump the metabolic syndrome? Yes. E Gale, BMJ 2008 336 640
15. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. R Kahn J Buse E Ferranninni M Stern, Diabetologia 2005 48 1684 1699 (Pubitemid 41317821)
16. Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? MP Stern K Williams SM Haffner, Ann Intern Med 2002 136 575 581 (Pubitemid 34407041)
17. Comparison of a clinical model, the oral glucose tolerance test, and fasting glucose for prediction of type 2 diabetes risk in Japanese Americans. MJ McNeely EJ Boyko DL Leonetti SE Kahn WY Fujimoto, Diabetes Care 2003 26 758 763
18. The diabetes risk score: a practical tool to predict type 2 diabetes risk. J Lindstrom J Tuomilehto, Diabetes Care 2003 26 725 731
19. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. RB D'Agostino Sr S Grundy LM Sullivan P Wilson, JAMA 2001 286 180 187
20. Estimation of cardiovascular risk: a comparison between the Framingham and the SCORE model in people under 60 years of age. T Scheltens WM Verschuren HC Boshuizen AW Hoes NP Zuithoff ML Bots, et al. Eur J Cardiovasc Prev Rehabil 2008 15 562 566
21. The quest for the optimal assessment of global cardioavascular risk: are traditional risk factors and metabolic syndrome partners in crime? BJ Arsenault P Pibarot JP Després, Cardiology 2008 113 35 49
22. General and abdominal adiposity and risk of death in Europe. T Pischon H Boeing K Hoffmann M Bergmann MB Schulze K Overvad YT van der Schouw E Spencer KG Moons A Tjønneland J Halkjaer MK Jensen J Stegger F Clavel-Chapelon MC Boutron-Ruault V Chajes J Linseisen R Kaaks A Trichopoulou D Trichopoulos C Bamia S Sieri D Palli R Tumino P Vineis S Panico PH Peeters AM May HB Bueno-de-Mesquita FJ van Duijnhoven G Hallmans L Weinehall J Manjer B Hedblad E Lund A Agudo L Arriola A Barricarte C Navarro C Martinez JR Quirás T Key S Bingham KT Khaw P Boffetta M Jenab P Ferrari E Riboli, NEJM 2008 359 2105 2120